JAKMIP2 Inhibitors
The chemical class termed JAKMIP2 inhibitors encompasses a range of compounds that can alter the biological activity of the JAKMIP2 protein through indirect means. These compounds are characterized by their ability to interfere with microtubule dynamics or disrupt the JAK-STAT signaling pathway. Microtubule-targeting agents, for instance, alter the polymerization and depolymerization equilibrium of tubulin, the building block of microtubules, thereby impacting the structural integrity and functional capacity of the cellular cytoskeleton. Since JAKMIP2 is posited to interact with microtubules, the stabilization or destabilization of microtubules by these agents can significantly impede JAKMIP2's ability to associate with these cytoskeletal elements, influencing its putative role in cellular transport, mitosis, and intracellular signaling.
Additionally, compounds that modulate the JAK-STAT pathway do so by inhibiting the activity of JAK kinases, which are upstream regulators in the pathway. The inhibition of JAK kinases results in decreased phosphorylation and activation of STAT transcription factors, which are pivotal in mediating the transcriptional responses to extracellular cytokine and growth factor signals. If JAKMIP2 functions within this signaling cascade, altering the JAK-STAT pathway can modulate the protein's activity. This modulation can affect the protein's role in various cellular processes, including proliferation, differentiation, and immune response regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, preventing their disassembly, which may affect JAKMIP2's interaction with microtubules. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Destabilizes microtubules, potentially disrupting JAKMIP2's microtubule-associated functions. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Binds tubulin and inhibits microtubule formation, which could impact JAKMIP2-related microtubule dynamics. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Inhibitor of JAK1 and JAK2 kinases; could affect JAKMIP2 if it interacts with JAK signaling pathways. | ||||||
AZD1480 | 935666-88-9 | sc-364735 sc-364735A | 5 mg 50 mg | $124.00 $1072.00 | 11 | |
Inhibits JAK1 and JAK2, which could modify the signaling environment of JAKMIP2. | ||||||
Baricitinib | 1187594-09-7 | sc-364730 sc-364730A | 5 mg 25 mg | $200.00 $664.00 | ||
Selectively inhibits JAK1 and JAK2, potentially affecting JAKMIP2's function if it is JAK-related. | ||||||
TG101348 | 936091-26-8 | sc-364740 sc-364740A | 5 mg 25 mg | $207.00 $515.00 | 6 | |
Selective inhibitor of JAK2, may influence JAKMIP2 activity in JAK-dependent signaling processes. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Binds tubulin and prevents its polymerization, potentially disrupting microtubule interactions with JAKMIP2. | ||||||
JAK Inhibitor I | 457081-03-7 | sc-204021 sc-204021A | 500 µg 1 mg | $156.00 $339.00 | 59 | |
Non-selective JAK inhibitor, could affect JAKMIP2's role in JAK-STAT signaling if applicable. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which could alter signaling pathways that intersect with JAKMIP2's functional scope. | ||||||